| 52-Week High | 219.57 |
|---|---|
| Last Price | 218.96 |
| Fibonacci 61.8% | 168.95 |
| Fibonacci 50% | 153.32 |
| Fibonacci 38.2% | 137.68 |
How much is a share of GW Pharmaceuticals worth?
One share of GWPH stock can currently be purchased for approximately $218.96. How much money does GW Pharmaceuticals make? GW Pharmaceuticals has a market capitalization of $6.86 billion and generates $311.33 million in revenue each year.
What does a hold rating mean for GW Pharmaceuticals (gwph)?
A hold rating indicates that analysts believe investors should maintain any existing positions they have in GWPH, but not buy additional shares or sell existing shares. View analyst ratings for GW Pharmaceuticals or view top-rated stocks. What stocks does MarketBeat like better than GW Pharmaceuticals?
What was the price of gwph on 27th May 2022?
Friday, 27th May 2022 GWPH stock ended at $218.96. During the day the stock fluctuated 0% from a day low at $218.96 to a day high of $218.96 . ... From 25 621, only a few dozen will trigger such a signal! Get Access to The Golden Star!
See more
Is GWPH a good stock to buy?
GW Pharma has 0.47% upside potential, based on the analysts' average price target. Can I see which stocks the top-ranking analysts are rating? Yes, go to the Analysts' Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
What is the stock symbol for GW Pharmaceuticals?
GW Pharmaceuticals trades on the NASDAQ under the ticker symbol "GWPH."
What happened to GW Pharmaceuticals?
DUBLIN , May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.
How much is GW Pharmaceuticals worth?
$6.81 BillionAs of July 2022 GW Pharmaceuticals has a market cap of $6.81 Billion.
What is GW Pharmaceuticals trading at?
Realtime quote and/or trades are not sourced from all markets....Key Turning Points.52-Week High219.57Last Price218.96Fibonacci 61.8%168.95Fibonacci 50%153.32Fibonacci 38.2%137.681 more row•May 4, 2021
How do I buy GW Pharmaceutical stock?
How to buy shares in GW PharmaceuticalsCompare share trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Who bought out GW Pharmaceuticals?
Jazz PharmaceuticalsA big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (JAZZ 1.44%), both companies announced in a joint press release.
Is GW Pharmaceuticals publicly traded?
GW Leads the Pack Another top performing publicly traded cannabis company was GW Pharmaceuticals, which was acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ) for $225 per share earlier this year.
Who owns GW Pharma?
Jazz PharmaceuticalsGW Pharmaceuticals / Parent organizationJazz Pharmaceuticals plc is a biopharmaceutical company based in Ireland. It was founded in 2003. One of the company's most significant products is the United States Food and Drug Administration approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid. Wikipedia
What company owns Epidiolex?
GW Pharmaceuticals' (GWPH) cannabidiol (CBD) drug Epidiolex has been granted Food and Drug Administration approval for a new indication. Additionally, its previous approval has been expanded to cover a wider age range of patients.
What is GW company?
GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas.
How many employees does GW Pharmaceuticals have?
Number of employees at GW Pharmaceuticals as of 2020, by function. As of December 2020, GW Pharmaceuticals had around 355 employees in the area of research and development, while there were 218 employees in management and administration.
How much did Jazz Pharmaceuticals pay for GW Pharmaceuticals?
$7.2 billionJazz agreed to pony up $7.2 billion for cannabinoid hotshot GW Pharmaceuticals, whose epilepsy med Epidiolex could be on its way to blockbuster sales. The deal will move Jazz into the epilepsy market, expanding its current offerings beyond sleep disorders and cancer.
Who makes Epidyolex?
GW Pharmaceuticals (GW), a subsidiary of Jazz Pharmaceuticals plc , has established a world-leading position in cannabinoid science and medicine. Founded over two decades ago in response to significant unmet patient need, patients remain our key focus and improving their quality of life, our motivation.
How many employees does GW Pharmaceuticals have?
Number of employees at GW Pharmaceuticals as of 2020, by function. As of December 2020, GW Pharmaceuticals had around 355 employees in the area of research and development, while there were 218 employees in management and administration.
Where is Epidiolex manufactured?
Manufactured by U.K.-based GW Pharmaceuticals, the cannabis drug is derived from a plant that has been bred to have a high cannabidiol, or CBD, content.